Appeal No. 08/911,596
Application No. 2001-2049
Claims 34-37, 39 and 43 stand rejected under 35 U.S.C.
102(a) as anticipated by Greiner.
Claims 1-33, 38 and 40-42 stand rejected under 35 U.S.C.
103. As evidence of obviousness, the examiner offers Greiner and
Voice Type with regard to claims 5, 38, 40 and 42, adding
Microsoft to this combination with regard to claims 1-4, 6-33 and
41. The User’s Guide is also applied with regard to claims 4 and
20 [Answer-page 5].
Reference is made to the briefs and answer for the
respective positions of appellant and the examiner.
OPINION
Claims 34-37, 39 and 43 are said, by the examiner, to be
anticipated by Greiner.
Under 35 U.S.C. 102, a reference must disclose, explicitly
or implicitly, every limitation of the claimed invention. Glaxo
Inc. v. Novopharm Ltd., 52 F.3d 1043, 1047, 34 USPQ2d 1565, 1567
(Fed. Cir.), cert. Denied, 516 U.S. 988 (1995).
Taking independent claim 34 as exemplary, the examiner
applies Greiner to the claim language as follows:
-3–
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007